About QuikClot: QuikClot® Hemostatic Products provide a bleeding control system that addresses bleeding scenarios from abrasions to traumatic injuries. QuikClot® is a proprietary technology, which consists of a non-woven material impregnated with kaolin. Kaolin activates Factor XII on the intrinsic pathway, which in turn accelerates the clotting cascade leading to faster bleeding control.*
About Teleflex: Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit www.Teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck® – trusted brands united by a common sense of purpose
*Data on file at Teleflex. Comparative data may not be indicative of clinical performance. Based on in-vitro testing when compared to standard gauze.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is QuikClot in?
QuikClot operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is QuikClot based?
QuikClot is headquartered in Morrisville, United States.
Find investors for your startup like QuikClot
Gritt sends AI-personalised outreach to each investor — from your Gmail
